1. Radiotherapy and immunotherapy: a beneficial liaison?
   Ralph R. Weichselbaum et al, 2017, Nature Reviews Clinical Oncology CrossRef
2. Programmed death-1 & its ligands: promising targets for cancer immunotherapy
   Rajeev K Shrimali et al, 2015, Immunotherapy CrossRef
3. Research Progress in Immunotherapy of NSCLC With EGFR-Sensitive Mutations
   Yudie Yang et al, 2022, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
4. Chronic Inflammation: Synergistic Interactions of Recruiting Macrophages (TAMs) and Eosinophils (Eos) with Host Mast Cells (MCs) and Tumorigenesis in CALTs. M-CSF, Suitable Biomarker for Cancer Diagnosis!
   Mahin Khatami, 2014, Cancers CrossRef
5. THE EYES HAVE IT ALL!
   Mahin Khatami, 2017, Inflammation, Aging and Cancer CrossRef
6. Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC
   Xue Li et al, 2018, Cancer Letters CrossRef
7. Semaphorin 4D in human head and neck cancer tissue and peripheral blood: A dense fibrotic peri-tumoral stromal phenotype
   Roshanak Derakhshandeh et al, 2018, Oncotarget CrossRef
8. PD0325901, an ERK inhibitor, enhances the efficacy of PD-1 inhibitor in non-small cell lung carcinoma
   Min Luo et al, 2021, Acta Pharmaceutica Sinica B CrossRef
9. Tumour–stroma crosstalk in the development of squamous cell carcinoma
   Yok Zuan Lim et al, 2014, The International Journal of Biochemistry & Cell Biology CrossRef
10. Pools of programmed death‐ligand within the oral cavity tumor microenvironment: Variable alteration by targeted therapies
    Sujay Shah et al, 2016, Head & Neck CrossRef
11. Isolation and identification of Candida species in patients with orogastric cancer: susceptibility to antifungal drugs, attributes of virulence in vitro and immune response phenotype
    Lourimar Viana Nascimento F. de Sousa et al, 2016, BMC Infectious Diseases CrossRef
12. Expression of programmed death 1 ligand 1 on periodontal tissue cells as a possible protective feedback mechanism against periodontal tissue destruction
    JIEHUA ZHANG et al, 2016, Molecular Medicine Reports CrossRef
13. Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
    Zuqiang Liu et al, 2017, Nature Communications CrossRef
14. Protein kinase D3 regulates the expression of the immunosuppressive protein, PD‑L1, through STAT1/STAT3 signaling
    Bomiao Cui et al, 2020, International Journal of Oncology CrossRef